An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes
No abstract is available for this record.
Bibliographic context
- Journal
- Neuroscience Applied
- Date
- 2025-12-31
- Source
- OpenAlex
- PubMed
- Unavailable
Topics and keywords
psilocybin DepressionPTSDChronic PainPharmacologyClinical TrialSafety Clinical Trial MedicineStress (linguistics)PsilocybinInternal medicineDepression (economics)Fight-or-flight responseClinical trialDiseasePharmacologyPlaceboPsychedelics and Drug StudiesPain Management and Placebo EffectDigital Mental Health Interventions
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.